<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04560504</url>
  </required_header>
  <id_info>
    <org_study_id>15102717</org_study_id>
    <nct_id>NCT04560504</nct_id>
  </id_info>
  <brief_title>Effectiveness of Oculomotor Training in Parkinson's Disease</brief_title>
  <official_title>Oculomotor Deficits in Parkinson's Disease: Enhancing Eye Movement Performance and Dynamic Visual Acuity With Oculomotor Training Using a Pilot Randomized Clinical Trial Design</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Hong Kong Polytechnic University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of California, Berkeley</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Deakin University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chinese University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Authority, Hong Kong</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The Hong Kong Polytechnic University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Parkinson's disease (PD) is a common neurodegenerative disorder which is characterized by&#xD;
      both motor and non-motor symptoms and usually affects people aged 50 years or above. Many&#xD;
      studies showed eye movement deficits and visual changes in patients with PD.&#xD;
&#xD;
      Previous studies have also indicated that clinical eye movement training could enhance the&#xD;
      functional performance of patients with various eye movement problems resulting from ocular&#xD;
      and neurodegenerative diseases.&#xD;
&#xD;
      In this study, we will investigate the effectiveness of eye movement training on dynamic&#xD;
      vision and functional performance in PD patients with oculomotor deficits.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">September 3, 2020</start_date>
  <completion_date type="Anticipated">September 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dynamic visual function</measure>
    <time_frame>Change from baseline at week 4 and change from baseline at week 12</time_frame>
    <description>Dynamic visual acuity is measured by a computerized programme, which participants are required to resolve the presented target with different speed and size</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oculomotor characteristics</measure>
    <time_frame>Change from baseline at week 4 and change from baseline at week 12</time_frame>
    <description>With the use of eye tracking device, eye movement behavior of participants can be measured and analysed while performing the following tasks.&#xD;
Fixation task - Fixate at stationary target presented on a monitor&#xD;
Saccade task - Follow and fixate at a random jumping target presented on a monitor&#xD;
Pursuit task - Follow accurately and steadily on a smooth moving target presented on a monitor&#xD;
Vergence task - Follow and fixate a jumping target presented in the anterior-posterior plane (jumping from 'far to near' or 'near to far')</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sentence reading performance</measure>
    <time_frame>Change from baseline at week 4 and change from baseline at week 12</time_frame>
    <description>To evaluate the effectiveness of the interventions on sentence reading using MNREAD charts in Chinese. These charts developed in our laboratory are used to measure the effectiveness of sentence reading in terms of reading speed and critical print size.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Passage reading performance</measure>
    <time_frame>Change from baseline at week 4 and change from baseline at week 12</time_frame>
    <description>To evaluate the effectiveness of the interventions on passage reading using International Reading speed Test (IReST). IReST is used to evaluate the effectiveness of passage reading performance by measuring the reading speed.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Parkinson Disease</condition>
  <condition>Oculomotor; Disorder</condition>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Receive 10 sessions of 45-minute (3 sessions per week) in-office leisure activities e.g. simple non-action computer games or board games (e.g. card and chess games) and 10-20 minutes of video watching at home</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Receive 10 sessions of 45-minute office training (3 sessions per week) and 10-20 minute home training (3 sessions per week) of eye movement training</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control Group</intervention_name>
    <description>Leisure activities</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Oculomotor Training Group</intervention_name>
    <description>Eye movement training</description>
    <arm_group_label>Intervention Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Parkinson's Disease diagnosed by a neurologist or geriatrician with the range of Stage&#xD;
&#xD;
             1 to 4 (Hoehn and Yahr Classification)&#xD;
&#xD;
          -  Able to speak and comprehend Cantonese dialect&#xD;
&#xD;
          -  Able to travel independently&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any congenital eye problem (e.g. congenital strabismus or amblyopia in either eye) or&#xD;
             any manifest eye diseases (e.g. macular degeneration, glaucoma, etc)&#xD;
&#xD;
          -  Severe medical problems (e.g. stroke)&#xD;
&#xD;
          -  Cognitive impairment (e.g. dementia)&#xD;
&#xD;
          -  Presence of any psychiatric or neurological diseases (apart from Parkinson's disease)&#xD;
             or receiving of any psychoactive pharmacological treatment&#xD;
&#xD;
          -  Receiving any medication that is known to affect eye movement and cognitive function&#xD;
&#xD;
          -  Previous formal vision rehabilitation or oculomotor intervention&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Allen Ming Yan Cheong, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Hong Kong Polytechnic University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Allen MY Cheong</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 7, 2020</study_first_submitted>
  <study_first_submitted_qc>September 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 23, 2020</study_first_posted>
  <last_update_submitted>October 18, 2021</last_update_submitted>
  <last_update_submitted_qc>October 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Hong Kong Polytechnic University</investigator_affiliation>
    <investigator_full_name>Allen MY Cheong</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Parkinson Disease</keyword>
  <keyword>Oculomotor deficit</keyword>
  <keyword>Oculomotor training</keyword>
  <keyword>Dynamic vision</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

